At a Pilates class, someone reportedly arrived with a paper lunch bag full of syringes. The syringes contained peptides, an ...

Research intended to help people with muscle-wasting diseases could be about to launch a new era in performance-enhancing drugs. The research has produced several muscle-building drugs now being ...

Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss. But along with the fat, many are quietly losing something else: muscle. Unlike fat, muscle doesn ...

GLP-1 drugs like semaglutide (Ozempic and Wegovy) have finally started to make weight loss a sustainable reality for many people with obesity. The ceiling of obesity treatment hasn’t been reached yet, ...

A drug called apitegromab may help preserve lean body mass during weight loss with tirzepatide, a GLP-1 receptor agonist, according to a phase 2 clinical trial published in Nature Medicine. The ...

Researchers have developed a new oral drug that boosts metabolic activity in muscle rather than altering appetite like GLP-1 drugs. Early trials suggest it improves blood sugar control and fat ...

New research presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) shows that following treatment with GLP-1 drugs for obesity, most weight loss is fat mass (80–85%) ...

Can you explain what Myomaker Bio's lab-grown human muscle platform is and the challenge it aims to address in drug development? Myomaker Bio develops three-dimensional human-derived muscle organs and ...